Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Atorvastatin on Subclinical Atherosclerosis in Virally-suppressed HIV-infected Patients With CMV Seropositivity: a Randomized Double-blind Placebo-controlled Trial

NCT04101136 is registered in ClinicalTrials.gov with Dr Cipto Mangunkusumo General Hospital as lead sponsor.

NCT NCT04101136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04101136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Atorvastatin on Subclinical Atherosclerosis in Virally-suppressed HIV-infected Patients With CMV Seropositivity: a Randomized Double-blind Placebo-controlled Trial
Lead sponsor
Dr Cipto Mangunkusumo General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2019
Completion date
July 15, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cmv